Matches in Wikidata for { <http://www.wikidata.org/entity/Q89940425> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- Q89940425 description "artículu científicu espublizáu en xineru de 2020" @default.
- Q89940425 description "im Januar 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89940425 description "scientific article published on 21 January 2020" @default.
- Q89940425 description "wetenschappelijk artikel" @default.
- Q89940425 description "наукова стаття, опублікована 21 січня 2020" @default.
- Q89940425 name "Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report" @default.
- Q89940425 name "Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report" @default.
- Q89940425 type Item @default.
- Q89940425 label "Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report" @default.
- Q89940425 label "Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report" @default.
- Q89940425 prefLabel "Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report" @default.
- Q89940425 prefLabel "Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report" @default.
- Q89940425 P1433 Q89940425-E840C316-D778-4C81-A94D-29EEA28D6042 @default.
- Q89940425 P1476 Q89940425-7E4C3C92-5F85-4547-8B79-7D2DF8E20961 @default.
- Q89940425 P2093 Q89940425-1ABD3C28-9D86-433E-8433-075FAB076180 @default.
- Q89940425 P2093 Q89940425-5BAEDCCB-01E7-45E4-B2F0-F19101EE37B2 @default.
- Q89940425 P2093 Q89940425-5E2D5E2A-8E9F-4650-A9AC-716FDD6E8AA0 @default.
- Q89940425 P2093 Q89940425-63656344-0A17-4130-AD5C-B5B0648EDE67 @default.
- Q89940425 P2093 Q89940425-8326CC27-313A-4E41-B493-CA94EB2BC3BA @default.
- Q89940425 P2860 Q89940425-0265E160-4D57-469B-8A4C-2CAC85CD0509 @default.
- Q89940425 P2860 Q89940425-1069A658-98A6-4F5D-A57F-AC67EA286E92 @default.
- Q89940425 P2860 Q89940425-1CF97F3C-9BA0-4267-B5B8-6A027FF0DF22 @default.
- Q89940425 P2860 Q89940425-21C9779B-3860-4E33-8DFC-03A59E6FD098 @default.
- Q89940425 P2860 Q89940425-2BF07CC3-5BA8-4C14-AA91-0AB9459E4E43 @default.
- Q89940425 P2860 Q89940425-42DE9EDF-85B3-4EBB-8BAF-75A6FB6C42DA @default.
- Q89940425 P2860 Q89940425-4799FBEA-E45A-4C0D-9D45-25D59EA07EB0 @default.
- Q89940425 P2860 Q89940425-6B5F9CF6-C90F-4FBC-BA01-CC5F1C961B87 @default.
- Q89940425 P2860 Q89940425-75E578E2-5928-4072-A447-0046189CC0BE @default.
- Q89940425 P2860 Q89940425-8681FD21-C602-4CE8-93EB-1DA297BC1F17 @default.
- Q89940425 P2860 Q89940425-976541B5-28F1-44E6-BF9F-7F2087038293 @default.
- Q89940425 P2860 Q89940425-9ECA552E-3B0E-451F-88DA-DD6A66CCA4B2 @default.
- Q89940425 P2860 Q89940425-AC00B470-1190-468E-A0C4-3AE2CD2D9917 @default.
- Q89940425 P2860 Q89940425-B3C02448-342A-4C04-A8FB-DD401B02150A @default.
- Q89940425 P2860 Q89940425-D89B789E-4F17-4684-BA02-FC58B7CB95DD @default.
- Q89940425 P2860 Q89940425-E5E38684-BBAB-48A8-BAA7-DA56632C107C @default.
- Q89940425 P304 Q89940425-8DA08551-30F9-4D79-A47A-3AE0EA758BF0 @default.
- Q89940425 P31 Q89940425-34475637-8179-41B8-8F47-AB7DDBE34ECD @default.
- Q89940425 P31 Q89940425-b5f280bb-92b6-4471-a559-7f56b433e003 @default.
- Q89940425 P356 Q89940425-F368C462-51B4-4140-9971-E803D4957896 @default.
- Q89940425 P433 Q89940425-CCF663F0-9BDB-4AC6-A52A-B2423C8F1B1A @default.
- Q89940425 P478 Q89940425-0987D574-FF87-4865-A383-C4718B96FAB3 @default.
- Q89940425 P577 Q89940425-45569C74-C99E-45FB-97AB-C2559084B4DC @default.
- Q89940425 P698 Q89940425-2168B272-47E6-4752-83AE-8A0D5EECC1C5 @default.
- Q89940425 P921 Q89940425-09642B1B-0315-4A1F-882E-D23C6F971DC6 @default.
- Q89940425 P921 Q89940425-925B09F0-653D-4EB9-90E2-0E8A02E093B0 @default.
- Q89940425 P921 Q89940425-C97E9C81-D9E5-4AC5-A34A-838882C41ED5 @default.
- Q89940425 P932 Q89940425-EC3171D6-7330-4453-9CD1-3D8C0430E249 @default.
- Q89940425 P356 000504930 @default.
- Q89940425 P698 32110218 @default.
- Q89940425 P1433 Q27722654 @default.
- Q89940425 P1476 "Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report" @default.
- Q89940425 P2093 "Keisuke Shirai" @default.
- Q89940425 P2093 "Lara K Ronan" @default.
- Q89940425 P2093 "Paula K Rauschkolb" @default.
- Q89940425 P2093 "Shodeinde Coker" @default.
- Q89940425 P2093 "Sivraj Muralikrishnan" @default.
- Q89940425 P2860 Q37281248 @default.
- Q89940425 P2860 Q38586991 @default.
- Q89940425 P2860 Q38687208 @default.
- Q89940425 P2860 Q38975751 @default.
- Q89940425 P2860 Q39009781 @default.
- Q89940425 P2860 Q41979947 @default.
- Q89940425 P2860 Q51610343 @default.
- Q89940425 P2860 Q51662069 @default.
- Q89940425 P2860 Q56888890 @default.
- Q89940425 P2860 Q56897418 @default.
- Q89940425 P2860 Q56897654 @default.
- Q89940425 P2860 Q56898955 @default.
- Q89940425 P2860 Q58599459 @default.
- Q89940425 P2860 Q60682608 @default.
- Q89940425 P2860 Q88854865 @default.
- Q89940425 P2860 Q90232531 @default.
- Q89940425 P304 "43-48" @default.
- Q89940425 P31 Q13442814 @default.
- Q89940425 P31 Q2782326 @default.
- Q89940425 P356 "10.1159/000504930" @default.
- Q89940425 P433 "1" @default.
- Q89940425 P478 "13" @default.
- Q89940425 P577 "2020-01-21T00:00:00Z" @default.
- Q89940425 P698 "32110218" @default.
- Q89940425 P921 Q13896859 @default.
- Q89940425 P921 Q18975855 @default.
- Q89940425 P921 Q205214 @default.
- Q89940425 P932 "7036588" @default.